Association of Ischemia-Modified Albumin (IMA) in Saliva, Serum, and Urine with Diagnosis of Chronic Kidney Disease (CKD) in Children: A Case-Control Study
Medical Science Monitor · 2023
DOI: 10.12659/msm.942230 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Medical Science Monitor, 2023. Verfasst von Julita Szulimowska und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Conservative Dentistry, Medical University of Białystok, Białystok, Poland. Hauptthemen laut MEDLINE: Saliva, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND Ischemia-modified albumin (IMA) is a secreted biomarker for ischemic oxidative stress. This case-control study aimed to evaluate the association of ischemia-modified albumin (IMA) in saliva, serum, and urine with diagnosis of chronic kidney disease (CKD) in 24 children. MATERIAL AND METHODS The study involved 24 children with CKD. CKD was defined according to the Kidney Disease Improving Global Outcomes (KDIGO) diagnostic criteria. The control group consisted of 24 healthy children who were matched for age and gender to the experimental group. The concentration of IMA was determined by the colorimetric method in non-stimulated whole saliva (NWS), stimulated whole saliva (SWS), serum, and urine of children with CKD. The Mann-Whitney U test was used for inter-group comparisons. RESULTS IMA levels were significantly higher in NWS (P=0.0082) and SWS (P=0.0014) of children with CKD than in the control group. The concentration of IMA in NWS was correlated with standard indicators of kidney function, including the estimated glomerular filtration rate (r=-0.798, P≤0.0001), stage of CKD (r=0.814, P≤0.0001), and serum creatinine (r=0.711, P≤0.0001) and urea levels (r=0.738, P≤0.0001). CONCLUSIONS Salivary IMA concentration depends on renal function in children. Salivary IMA discriminates children with end-stage kidney disease from children with mild and moderate CKD and healthy children with high sensitivity and specificity. Further research is required, including assessment of the diagnostic usefulness and validation of the biomarker in a clinical diagnostic study.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Conservative Dentistry, Medical University of Białystok, Białystok, Poland.
- Department of Pediatrics and Nephrology, Medical University of Białystok, Białystok, Poland.
- Students' Scientific Club "Biochemistry of Civilization Diseases" at the Department of Hygiene, Epidemiology and Ergonomics, Medical University of Białystok, Białystok, Poland.
- Department of Hygiene, Epidemiology and Ergonomics, Medical University of Białystok, Białystok, Poland.
- Department of Medicine, Faculty of Medical Sciences and Health Sciences, Kazimierz Pułaski University in Radom, Radom, Poland.
ORCID-Profile: Julita Szulimowska, Katarzyna Taranta-Janusz, Małgorzata Żendzian-Piotrowska, Ryszard Tomasiuk, Mateusz Maciejczyk
Zitieren
APA
Szulimowska, J., Zalewska, A., Taranta-Janusz, K., Trocka, D., Żendzian-Piotrowska, M., Tomasiuk, R., & Maciejczyk, M. (2023). Association of Ischemia-Modified Albumin (IMA) in Saliva, Serum, and Urine with Diagnosis of Chronic Kidney Disease (CKD) in Children: A Case-Control Study. Medical Science Monitor. https://doi.org/10.12659/msm.942230
Vancouver
Szulimowska J, Zalewska A, Taranta-Janusz K, Trocka D, Żendzian-Piotrowska M, Tomasiuk R, et al. Association of Ischemia-Modified Albumin (IMA) in Saliva, Serum, and Urine with Diagnosis of Chronic Kidney Disease (CKD) in Children: A Case-Control Study. Medical Science Monitor. 2023. doi:10.12659/msm.942230
BibTeX
@article{Szulimowska2023,
author = {Szulimowska, Julita and Zalewska, Anna and Taranta-Janusz, Katarzyna and Trocka, Daria and Żendzian-Piotrowska, Małgorzata and Tomasiuk, Ryszard and Maciejczyk, Mateusz},
title = {Association of Ischemia-Modified Albumin (IMA) in Saliva, Serum, and Urine with Diagnosis of Chronic Kidney Disease (CKD) in Children: A Case-Control Study},
journal = {Medical Science Monitor},
year = {2023},
doi = {10.12659/msm.942230}
}
EUVIMED